Glucagon-like peptide-1 (GLP-1) agonists, which improve insulin secretion, decrease glucagon secretion, increase satiety (and therefore decrease food intake), and may have beneficial effects on beta-cell function, represent an important addition to treatment options
Elevated hsCRP correlates with disease activity, cardiovascular risk, and kidney involvement
Mar 3, 2026 Some researchers split their retatrutide dose into two or three smaller injections per week and report fewer side effects
I needed a change to feel better and be healthier, he said
The article frames phentermine as suited to rapid reduction for a specific event or as a bridge into lifestyle change, not as chronic weight management